Key result
PCI for MI in severe CKD is linked to ~18% in-hospital mortality.
Why the study?
In-hospital mortality and MACE in acute coronary syndrome patients with severe CKD undergoing PCI needed to be determined.
Cohort (n=160)
No
Acute coronary syndrome patients with severe chronic kidney disease undergoing PCI experience high rates of in-hospital MACE and mortality, highlighting the need for individualized care.
Answers are grounded in this paper and cite their sources.
High in-hospital MACE and mortality after PCI in AMI with severe CKD urge caution; observational data leaves optimal strategies open for trials.
Objective: To determine in-hospital mortality and major adverse cardiac events (MACE) in acute coronary syndrome (AMI) patients with underlying severe chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI). Methods: We conducted a retrospective cohort study from June’2013-December’2017 at Tabba Heart Institute, Karachi. Data was drawn from institutes’ database modeled after US National Cardiovascular data CathPCI registry. All AMI (STEMI: ST-elevation myocardial infarction and NSTEMI: non-ST-elevation myocardial infarction) patients undergoing PCI with creatinine clearance <30ml/min or ESRD on hemodialysis were included in the study. Results: During 54 months study period, 160 severe CKD patients underwent PCI. Mean age was 62.9±12.2 years. Men were 61.9%, hypertensive (81.3%) and diabetic (63.8%). Excluding dialysis patients, Creatinine clearance was 21.1±6.6ml/min/1.73m2. STEMI were 46.9% and 61.9% were Killip I. Mean SYNTAX score was 16.6±7.3. MACE occurred in 32.5% patients, of which 6(11.5%) had new hemodialysis and mortality: 17.5% were deceased. MACE predictor were cardiogenic shock (OR: 2.81, 95%CI: 1.17-6.74) and prior heart failure (OR: 6.84, 95%CI: 1.39-33.74), Predictor of mortality was cardiogenic shock or cardiac arrest (OR: 7.90, 95%CI: 2.95-21.17). Conclusion: Severe CKD patients undergoing PCI for AMI have drastically poor outcomes therefore individualization and patient-centric care management is mandatory. How to cite this:Sattar S, Ahmed N, Akhter Z, Aijaz S, Lakhani S, Malik R, et al. In-Hospital outcomes in acute coronary syndrome patients with concomitant severe chronic kidney disease undergoing percutaneous coronary intervention. Pak J Med Sci. 2019;35(2):291-297. doi: https://doi.org/10.12669/pjms.35.2.276 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
No takes yet. Share an insight, caveat, or question.
Sattar et al. (2019) conducted a cohort in Acute coronary syndrome with severe chronic kidney disease (n=160). Percutaneous coronary intervention was evaluated on In-hospital mortality. In patients with acute myocardial infarction and severe chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: